secwatch.observer — SEC 8-K summary
======================================

Issuer:     Contineum Therapeutics, Inc. (CTNM)
CIK:        0001855175
Form:       8-K
Filed at:   2026-07-13T20:15:17+00:00
Accession:  0001628280-26-048023
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Contineum Therapeutics updates corporate presentation; specifics not disclosed in filing
--------------------------------------------------------------------------------

- Company furnished an updated corporate presentation as Exhibit 99.1 on July 13, 2026.
- Presentation will be posted on company website; no further 8-K for future updates.
- No specific business or strategic updates are detailed in the 8-K body or provided exhibit text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855175/000162828026048023/0001628280-26-048023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855175/000162828026048023/ctnm-20260713.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-048023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer